Thorsten Rosenbaum

Department Head

Sana Klinikum Lichtenberg

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Medical Imaging Medical Imaging professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Thorsten Rosenbaum is the Department Head at Sana Kliniken Duisburg, Germany. His research focuses on neurofibromatosis type 1, including diagnostic evaluation and treatment, management of associated adverse events, and therapeutic options such as MEK inhibitors. He has contributed significantly to the understanding of neurofibromatosis through recent publications addressing surgical interventions and clinical characterization of patients.

Articles (9)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2021

Year:

2021

Year:

2020

Collaborators (2)

Walter Taal

Erasmus University Rotterdam

NETHERLANDS

View details

Amedeo Azizi

Assoc. Prof.

Medical University of Vienna

AUSTRIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Thorsten Rosenbaum

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

Age-Adapted Diagnostic Evaluation and Treatment of Patients With Type 1 Neurofibromatosis in Germany.

Consensus recommendations on management of selumetinib-associated adverse events in pediatric patients with neurofibromatosis type 1 and plexiform neurofibromas.

ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1

Correction to: A chance to cut is a chance to cure: complete resection of an atypical neurofibroma prevents further progression to malignancy.

A chance to cut is a chance to cure: complete resection of an atypical neurofibroma prevents further progression to malignancy.

Doppler Ultrasound Flow Reversal in the Superior Sagittal Sinus to Detect Cerebral Venous Congestion in Vein of Galen Malformation

Treatment of Plexiform Neurofibromas with MEK Inhibitors: First Results with a New Therapeutic Option.

Neurofibromatosis Type 1 With Cherubism-like Phenotype, Multiple Osteolytic Bone Lesions of Lower Extremities, and Alagille-syndrome: Case Report With Literature Survey.

Clinical characterization of children and adolescents with NF1 microdeletions.

Collaborators (2)

Walter Taal

Amedeo Azizi

Make your next move.